Back to search

National and Kapodistrian University of Athens

Μοριακός φαινότυπος των καρκινωμάτων της ανώτερης αποχετευτικής μοίρας του ουροποιητικού συστήματος

Abstract

dc:description

Upper Urinary Tract Tumors (renal pelvis and ureter) represent arare disease, not well studied. They come from the transitional epitheliumand account only for 5% of all urothelial carcinomas. Tumor stage andgrade are the only established prognostic factors. The aggressive nature,however, of this tumor along with the unpredictable, usually, clinicalcourse, render the identification of novel therapeutic approaches ratheressential. The ErbB family receptors are a field for research of highinterest and targeted therapies are already being used for other types ofcancer. This study aimed to correlate ErbB2, ErbB3 and ErbB4expression in Upper Urinary Tract Urothelial Carcinoma (UUTUC) withother clinicopathological parameters as well as patient outcome. ErbB2, ErbB3 and ErbB4 were immunohistochemically assessed in99 consecutive UUTUC specimens. All statistical analyses wereperformed using the SPSS statistical program, version 16. Overall, 28,3% of patients died during the follow-up of 127months, 1-95 months after the first surgical treatment and mean survivalwas 18,9±24,2 months. ErbB2, ErbB3 and ErbB4 expression was presentin 64,8%, 19,5%, and 20,8% of tumors, respectively. Combinedexpression of all three receptors was found in 7,9% of the tumors,combined expression of two receptors in 14,5% and 48,7% expressed atleast one ErbB receptor. No ErbB expression was found in 28,9% oftumors. We found no significant correlation between ErbB2, ErbB3 andErbB4 expression with tumor stage, grade, recurrence or cancer specificsurvival apart from the inverse relation between ErbB2 expression andtime to recurrence (p=0.027). In conclusion, of the three receptors we evaluated, neither ErbB3nor ErbB4 have any prognostic significance in the UUTUC. ErbB2, however, is inversely related to recurrence and, although this is notenough to justify the introduction of anti-ErbB treatment in everydayclinical practice, it needs further evaluation in well designed, prospective,randomized trials.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Galanakis, Ioannis
  • Γαλανάκης, Ιωάννης

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41255

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Galanakis, Ioannis; Γαλανάκης, Ιωάννης. Μοριακός φαινότυπος των καρκινωμάτων της ανώτερης αποχετευτικής μοίρας του ουροποιητικού συστήματος. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/41255